Prof. Joseph D Rosenblatt

Joseph D Rosenblatt is Professor of Medicine, Microbiology and Immmunology at the University of Miami Miller School of Medicine , and currently serves as the William Harrington Professor of Hematology and Chief of the University of Miami Division of Hematology.
He previously served as chief of the combined Division of Hematology – Oncology from 2001-2017, when Hematology became a separate Division. Rosenblatt also currently serves as Associate Director for Faculty Development in the Sylvester Comprehensive Cancer Center and previously served as Interim Director of the Sylvester Comprehensive Cancer Center from 2010-2012. From 2001 -2017 he served as Associate Director for Clinical and Translational Research within the Sylvester Comprehensive Cancer Center.
Dr. Rosenblatt joined UM/Sylvester in September 2001 from the University of Rochester where he served as the Chief of the Hematology-Oncology Unit and Associate Director for Clinical Research at the James P. Wilmot Cancer Center from 1995-2001. He completed Medical School, Residency and Hematology –Oncology fellowship training at the University of California at Los Angeles , where he joined the faculty rising to the rank of Associate Professor.
Professor Rosenblatt is well known for research in the areas of human retroviruses, immune therapies for cancer, human gene therapy and antibody engineering has been a principal investigator on numerous grants from the National Institutes of Health, US Department of Defense, American Cancer Society and the Leukemia and Lymphoma Society of America.
He is a former member of National Cancer Institute Experimental Therapeutics II, and Clinical Immunology and Immunotherapy study sections, and has been a three time and current member of the international Israel Cancer Research Fund Scientific Review Panel.
DR Rosenblatt maintains an active clinical practice focused on lymphoid and other hematologic malignancies and has served as Principal Investigator on multiple clinical trials. Rosenblatt has served on scientific advisory panels for Merck, Seattle Genetics, Kite among others and most recently for Synergys – a biotechnology startup. He recently has been an academic co-investigator on two NCI SBIR grants.